radiance

Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug ConjugateRadiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate

Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate

BOSTON, Massachusetts, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., ("Radiance" or the "Company"), a biotechnology company, today announced…

2 months ago
Radiance has been selected to Present at the 2025 Biotech Showcase Alongside the J.P. Morgan Healthcare ConferenceRadiance has been selected to Present at the 2025 Biotech Showcase Alongside the J.P. Morgan Healthcare Conference

Radiance has been selected to Present at the 2025 Biotech Showcase Alongside the J.P. Morgan Healthcare Conference

January 15, 2025 16:50 ET  | Source: Radiance BioPharma BOSTON, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc. a…

3 months ago